The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Hepatitis B virus-induced oncogenesis
Open accessAbstract
Hepatocellular carcinoma (HCC) is one of the most common cancers in the world with an annual incidence of more than 500000 in the year 2000. Its incidence is rising in many countries. Recently, it has been estimated that about 53% of HCC cases in the world are related to hepatitis B virus (HBV). The epidemiological association of HBV with HCC is well established. In recent studies, it was revealed that HBsAg carriers have a 25-37 times increased risk of developing HCC as compared to non-infected people. At present, HBV-associated carcinogenesis can be seen as a multi-factorial process that includes both direct and indirect mechanisms that might act synergistically. The integration of HBV DNA into the host genome occurs at early steps of clonal tumor expansion. The integration has been shown in a number of cases to affect a variety of cancer-related genes and to exert insertional mutagenesis. The permanent liver inflammation, induced by the immune response, resulting in a degeneration and regeneration process confers to the accumulation of critical mutations in the host genome. In addition to this, the regulatory proteins HBx and the PreS2 activators that can be encoded by the integrate exert a tumor promoter-like function resulting in positive selection of cells producing a functional regulatory protein. Gene expression profiling and proteomic techniques may help to characterize the molecular mechanisms driving HBV-associated carcinogenesis, and thus potentially identify new strategies in diagnosis and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
The Function and Mechanism of Promoters of Carcinogenesis
Boutwell, R. K., & Sivak, A. (1973) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447309025704 · Cited by 746
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
Brechot, C., Pourcel, C., Louise, A., Rain, B., & Tiollais, P. (1980) · Nature · doi:10.1038/286533a0 · Cited by 612
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Shibuya, K., Mathers, C. D., Boschi-Pinto, C., Lopez, A. D., & Murray, C. J. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-37 · Cited by 467
HBV X Protein Alters the DNA Binding Specificity of CREB and ATF-2 by Protein-Protein Interactions
Maguire, H. F., Hoeffler, J. P., & Siddiqui, A. (1991) · Science · doi:10.1126/science.1827531 · Cited by 454
Woodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C. A., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 440
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
Pollicino, T., Squadrito, G., Cerenzia, G., Cacciola, I., Raffa, G., Craxı̀, A., Farinati, F., Missale, G., Smedile, A., Tiribelli, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.048 · Cited by 427
Benn, J., & Schneider, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10350 · Cited by 418
Calcium Signaling by HBx Protein in Hepatitis B Virus DNA Replication
Bouchard, M. J., Wang, L.-H., & Schneider, R. J. (2001) · Science · doi:10.1126/science.294.5550.2376 · Cited by 385
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
Kekulé, A. S., Lauer, U., Weiss, L., Luber, B., & Hofschneider, P. H. (1993) · Nature · doi:10.1038/361742a0 · Cited by 369
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Paterlini-Bréchot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., & Bréchot, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206492 · Cited by 354
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Waris, G., Huh, K.-W., & Siddiqui, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7721-7730.2001 · Cited by 318
Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma
MONTALTO, G., CERVELLO, M., GIANNITRAPANI, L., DANTONA, F., TERRANOVA, A., & CASTAGNETTA, L. A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04090.x · Cited by 312
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
A Transgenic Mouse Model of the Chronic Hepatitis B Surface Antigen Carrier State
Chisari, F. V., Pinkert, C. A., Milich, D. R., Filippi, P., McLachlan, A., Palmiter, R. D., & Brinster, R. L. (1985) · Science · doi:10.1126/science.3865369 · Cited by 290
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours
Fourel, G., Trepo, C., Bougueleret, L., Henglein, B., Ponzetto, A., Tiollais, P., & Buendia, M.-A. (1990) · Nature · doi:10.1038/347294a0 · Cited by 249
Molecular pathogenesis of human hepatocellular carcinoma
Wang, X. W., Hussain, S. P., Huo, T.-I., Wu, C.-G., Forgues, M., Hofseth, L. J., Brechot, C., & Harris, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00253-6 · Cited by 246
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier, M., Hussain, S. P., de Fromentel, C. C., Hainaut, P. L., & Harris, C. C. (2004) · PubMed · Cited by 243
Staib, F., Perwez Hussain, S., Hofseth, L. J., Wang, X. W., & Harris, C. C. (2003) · Human Mutation · doi:10.1002/humu.10176 · Cited by 241
Kang, X.-Q. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i47.7391 · Cited by 237
Activation of Src Family Kinases by Hepatitis B Virus HBx Protein and Coupled Signaling to Ras
Klein, N. P., & Schneider, R. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6427 · Cited by 231
Ni, Y.-H., Chang, M.-H., Wang, K.-J., Hsu, H.-Y., Chen, H.-L., Kao, J.-H., Yeh, S.-H., Jeng, Y.-M., Tsai, K.-S., & Chen, D.-S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.048 · Cited by 213
Meyer, M., Caselmann, W. H., Schlüter, V., Schreck, R., Hofschneider, P. H., & Baeuerle, P. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05369.x · Cited by 203
Bruss, V., Lu, X., Thomssen, R., & Gerlich, W. H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06509.x · Cited by 201
Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
Dunsford, H. A., Sell, S., & Chisari, F. V. (1990) · PubMed · Cited by 198
Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma
Hsu, T.-Y., Möröy, T., Etiemble, J., Louise, A., Trépo, C., Tiollais, P., & Buendia, M.-A. (1988) · Cell · doi:10.1016/0092-8674(88)90221-8 · Cited by 192
Ahn, S. H., Park, Y. N., Park, J. Y., Chang, H.-Y., Lee, J. M., Shin, J. E., Han, K.-H., Park, C., Moon, Y. M., & Chon, C. Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.026 · Cited by 186
Effects of hepatitis B virus X protein on the development of liver cancer
Zhang, X., Zhang, H., & Ye, L. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.10.003 · Cited by 181
Cougot, D., Neuveut, C., & Buendia, M. A. (2005) · Journal of Clinical Virology · doi:10.1016/s1386-6532(05)80014-9 · Cited by 177
Human Hepatitis B Virus-X Protein Alters Mitochondrial Function and Physiology in Human Liver Cells
Lee, Y. I., Hwang, J. M., Im, J. H., Lee, Y. I., Kim, N. S., Kim, D. G., Yu, D. Y., Moon, H. B., & Park, S. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309280200 · Cited by 171
Kao, J., Chen, P., Lai, M., & Chen, D. (2004) · Journal of Medical Virology · doi:10.1002/jmv.10534 · Cited by 170
Specific mutations of hepatitis B virus in plasma predict liver cancer development
Kuang, S.-Y., Jackson, P. E., Wang, J.-B., Lu, P.-X., Muñoz, A., Qian, G.-S., Kensler, T. W., & Groopman, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308232100 · Cited by 165
The Hepatitis B Virus Large Surface Protein (LHBs) Is a Transcriptional Activator
Hildt, E., Saher, G., Bruss, V., & HOFSCHNEIDER, P. H. (1996) · Virology · doi:10.1006/viro.1996.0594 · Cited by 151
Caselmann, W., Meyer, M. S., Kekulé, A. S., Lauer, U. M., HOFSCHNEIDER, P. H., & Koshy, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2970 · Cited by 146
Sugauchi, F., Kumada, H., Acharya, S. A., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79811-0 · Cited by 143
Functional Genomics of Hepatocellular Carcinoma
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Hepatology · doi:10.1002/hep.21063 · Cited by 137
Transcriptional repression of the human p53 gene by hepatitis B viral X protein
Lee, S., & Rho, H. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203312 · Cited by 127
Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma
Jüngst, C., Cheng, B., Gehrke, R., Schmitz, V., Nischalke, H. D., Ramakers, J., Schramel, P., Schirmacher, P., Sauerbruch, T., & Caselmann, W. H. (2004) · Hepatology · doi:10.1002/hep.20241 · Cited by 126
Molecular Mechanism of Viral Hepatocarcinogenesis
Koike, K., Tsutsumi, T., Fujie, H., Shintani, Y., & Moriya, K. (2002) · Oncology · doi:10.1159/000048273 · Cited by 123
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3851-3858.2001 · Cited by 120
Sirma, H., Weil, R., Rosmorduc, O., Urban, S., Israël, A., Kremsdorf, D., & Bréchot, C. (1998) · Oncogene · doi:10.1038/sj.onc.1201737 · Cited by 106
Bouchard, M. J., Wang, L., & Schneider, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4406-4414.2006 · Cited by 99
cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome
Horikawa, I., & Barrett, J. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1171 · Cited by 96
Regulatory mechanisms of viral hepatitis B and C
Waris, G., & Siddiqui, A. (2003) · Journal of Biosciences · doi:10.1007/bf02970150 · Cited by 87
Stimulation of Cellular Proliferation by Hepatitis B Virus X Protein
Madden, C. R., & Slagle, B. L. (2001) · Disease Markers · doi:10.1155/2001/571254 · Cited by 64
Characterization of the mitochondrial association of hepatitis B virus X protein, HBx
Huh, K.-W., & Siddiqui, A. (2002) · Mitochondrion · doi:10.1016/s1567-7249(01)00040-x · Cited by 53
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5266-5272.2000 · Cited by 52
Hepatitis B viruses and cancerogenesis
Buendia, M. (1998) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86239-7 · Cited by 51
Immunopathogenesis: Role of Innate and Adaptive Immune Responses
Visvanathan, K., & Lewin, S. (2006) · Seminars in liver disease (Print) · doi:10.1055/s-2006-939755 · Cited by 44
Stöckl, L., Berting, A., Malkowski, B., Foerste, R., HOFSCHNEIDER, P. H., & Hildt, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206320 · Cited by 43
Telomerase Activation in Human Hepatocarcinogenesis
Hytiroglou, P., & Theise, N. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00521.x · Cited by 26
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 277
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer
Fernandez, A. F., Rosales, C., Lopez-Nieva, P., Graña, O., Ballestar, E., Ropero, S., Espada, J., Melo, S. A., Lujambio, A., Fraga, M. F., et al. (2009) · Genome Research · doi:10.1101/gr.083550.108 · Cited by 255
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Metadata
- Authors
- Lupberger, J.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2007
- Volume
- 13
- Issue
- 1
- Pages
- 74
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1971673379
- Cited by
- 267
- References
- 72
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.